Insider Transactions in Q1 2021 at Travelers Companies, Inc. (TRV)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2021
|
Clarence Otis Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
257
+2.35%
|
$38,550
$150.4 P/Share
|
Mar 31
2021
|
Elizabeth Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
216
+6.16%
|
$32,400
$150.4 P/Share
|
Feb 25
2021
|
Andy F Bessette EVP and Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
2,000
-14.38%
|
$298,000
$149.58 P/Share
|
Feb 25
2021
|
Andy F Bessette EVP and Chief Admin Officer |
SELL
Bona fide gift
|
Direct |
680
-4.66%
|
-
|
Feb 24
2021
|
Maria Olivo EVP, Strat Dev & Pres Intl |
SELL
Open market or private sale
|
Direct |
10,000
-9.52%
|
$1,500,000
$150.63 P/Share
|
Feb 24
2021
|
Maria Olivo EVP, Strat Dev & Pres Intl |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.69%
|
$590,000
$59.74 P/Share
|
Feb 24
2021
|
William H Heyman Vice Chairman |
SELL
Open market or private sale
|
Direct |
4,500
-0.9%
|
$675,000
$150.63 P/Share
|
Feb 24
2021
|
William H Heyman Vice Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+1.77%
|
$477,000
$106.03 P/Share
|
Feb 23
2021
|
William H Heyman Vice Chairman |
SELL
Open market or private sale
|
Direct |
3,000
-1.21%
|
$447,000
$149.44 P/Share
|
Feb 23
2021
|
William H Heyman Vice Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+1.19%
|
$318,000
$106.03 P/Share
|
Feb 23
2021
|
Gregory C Toczydlowski EVP & President, Business Ins. |
SELL
Open market or private sale
|
Direct |
11,536
-30.11%
|
$1,707,328
$148.85 P/Share
|
Feb 23
2021
|
Gregory C Toczydlowski EVP & President, Business Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,941
+25.61%
|
$555,280
$80.35 P/Share
|
Feb 17
2021
|
Andy F Bessette EVP and Chief Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,224
-13.23%
|
$326,928
$147.79 P/Share
|
Feb 17
2021
|
Andy F Bessette EVP and Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,158
+23.48%
|
-
|
Feb 17
2021
|
Daniel S. Frey EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
668
-22.28%
|
$98,196
$147.79 P/Share
|
Feb 17
2021
|
Daniel S. Frey EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,436
+32.39%
|
-
|
Feb 17
2021
|
William H Heyman Vice Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
6,275
-2.49%
|
$922,425
$147.79 P/Share
|
Feb 17
2021
|
William H Heyman Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
11,790
+4.48%
|
-
|
Feb 17
2021
|
William H Heyman Vice Chairman |
SELL
Open market or private sale
|
Direct |
3,000
-1.24%
|
$444,000
$148.25 P/Share
|
Feb 17
2021
|
William H Heyman Vice Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+1.22%
|
$318,000
$106.03 P/Share
|
Feb 17
2021
|
Avrohom J. Kess Vice Chmn & Chief Legal Off |
SELL
Payment of exercise price or tax liability
|
Direct |
6,275
-20.28%
|
$922,425
$147.79 P/Share
|
Feb 17
2021
|
Avrohom J. Kess Vice Chmn & Chief Legal Off |
BUY
Grant, award, or other acquisition
|
Direct |
11,790
+27.59%
|
-
|
Feb 17
2021
|
Michael Frederick Klein EVP & President, Personal Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,707
-46.44%
|
$544,929
$147.79 P/Share
|
Feb 17
2021
|
Michael Frederick Klein EVP & President, Personal Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
7,982
+50.0%
|
-
|
Feb 17
2021
|
Thomas M Kunkel EVP & Pres., Bond & Spec. Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,717
-9.43%
|
$546,399
$147.79 P/Share
|
Feb 17
2021
|
Thomas M Kunkel EVP & Pres., Bond & Spec. Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
7,982
+16.85%
|
-
|
Feb 17
2021
|
Diane Kurtzman EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-19.7%
|
$36,897
$147.79 P/Share
|
Feb 17
2021
|
Diane Kurtzman EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
736
+36.62%
|
-
|
Feb 17
2021
|
Maria Olivo EVP, Strat Dev & Pres Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
3,104
-3.16%
|
$456,288
$147.79 P/Share
|
Feb 17
2021
|
Maria Olivo EVP, Strat Dev & Pres Intl |
BUY
Grant, award, or other acquisition
|
Direct |
6,386
+6.11%
|
-
|
Feb 17
2021
|
Douglas K Russell SVP, Corp Contr & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
521
-2.54%
|
$76,587
$147.79 P/Share
|
Feb 17
2021
|
Douglas K Russell SVP, Corp Contr & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
1,658
+7.48%
|
-
|
Feb 17
2021
|
Alan D Schnitzer Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,440
-10.79%
|
$3,151,680
$147.79 P/Share
|
Feb 17
2021
|
Alan D Schnitzer Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,282
+16.86%
|
-
|
Feb 17
2021
|
Gregory C Toczydlowski EVP & President, Business Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,002
-18.34%
|
$588,294
$147.79 P/Share
|
Feb 17
2021
|
Gregory C Toczydlowski EVP & President, Business Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
8,597
+28.27%
|
-
|
Feb 10
2021
|
Michael Frederick Klein EVP & President, Personal Ins. |
SELL
Open market or private sale
|
Direct |
23,230
-100.0%
|
$3,391,580
$146.25 P/Share
|
Feb 10
2021
|
Michael Frederick Klein EVP & President, Personal Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
23,230
+50.0%
|
$1,858,400
$80.35 P/Share
|
Feb 02
2021
|
Alan L Beller Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+3.23%
|
$174,028
$139.83 P/Share
|
Feb 02
2021
|
Janet M Dolan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+2.52%
|
$174,028
$139.83 P/Share
|
Feb 02
2021
|
Patricia Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+3.22%
|
$174,028
$139.83 P/Share
|
Feb 02
2021
|
William J Kane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+6.14%
|
$174,028
$139.83 P/Share
|
Feb 02
2021
|
Clarence Otis Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+10.79%
|
$174,028
$139.83 P/Share
|
Feb 02
2021
|
Elizabeth Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+29.08%
|
$174,028
$139.83 P/Share
|
Feb 02
2021
|
Philip T Ruegger Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+3.33%
|
$174,028
$139.83 P/Share
|
Feb 02
2021
|
Todd C Schermerhorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+12.56%
|
$174,028
$139.83 P/Share
|
Feb 02
2021
|
Laurie J Thomsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+2.3%
|
$174,028
$139.83 P/Share
|
Jan 26
2021
|
William H Heyman Vice Chairman |
SELL
Open market or private sale
|
Direct |
3,000
-1.24%
|
$441,000
$147.25 P/Share
|
Jan 26
2021
|
William H Heyman Vice Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+1.22%
|
$318,000
$106.03 P/Share
|
Jan 25
2021
|
William H Heyman Vice Chairman |
SELL
Open market or private sale
|
Direct |
4,000
-1.64%
|
$584,000
$146.25 P/Share
|